Does the media refer more to THC or SGRY?

In the previous week, Surgery Partners had 2 more articles in the media than Tenet Healthcare. MarketBeat recorded 3 mentions for Surgery Partners and 1 mentions for Tenet Healthcare. Surgery Partners' average media sentiment score of 0.93 beat Tenet Healthcare's score of 0.83 indicating that Surgery Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tenet Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Surgery Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SGRY or HIMS?

In the previous week, Hims & Hers Health had 10 more articles in the media than Surgery Partners. MarketBeat recorded 13 mentions for Hims & Hers Health and 3 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.93 beat Hims & Hers Health's score of 0.63 indicating that Surgery Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer SGRY or PACS?

In the previous week, PACS Group had 10 more articles in the media than Surgery Partners. MarketBeat recorded 13 mentions for PACS Group and 3 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.93 beat PACS Group's score of 0.07 indicating that Surgery Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 3 Very Positive mention(s) 7 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to SGRY or BLLN?

In the previous week, Billiontoone had 11 more articles in the media than Surgery Partners. MarketBeat recorded 14 mentions for Billiontoone and 3 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.93 beat Billiontoone's score of -0.17 indicating that Surgery Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Is RDNT or SGRY more profitable?

RadNet has a net margin of -0.66% compared to Surgery Partners' net margin of -2.28%. RadNet's return on equity of 2.77% beat Surgery Partners' return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% Surgery Partners -2.28% 1.04% 0.41%

Does the media refer more to RDNT or SGRY?

In the previous week, RadNet and RadNet both had 3 articles in the media. RadNet's average media sentiment score of 1.38 beat Surgery Partners' score of 0.93 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Surgery Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Surgery Partners (SGRY) Competitors

$15.18 -0.80 (-5.02%)

As of 10:57 AM Eastern

Compare

SGRY vs. THC, HIMS, PACS, BLLN, and RDNT

Should you buy Surgery Partners stock or one of its competitors? MarketBeat compares Surgery Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Surgery Partners include Tenet Healthcare (THC), Hims & Hers Health (HIMS), PACS Group (PACS), Billiontoone (BLLN), and RadNet (RDNT).

How does Surgery Partners compare to Tenet Healthcare?

Tenet Healthcare (NYSE:THC) and Surgery Partners (NASDAQ:SGRY) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

95.4% of Tenet Healthcare shares are owned by institutional investors. 1.0% of Tenet Healthcare shares are owned by insiders. Comparatively, 2.0% of Surgery Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Tenet Healthcare currently has a consensus target price of $245.37, suggesting a potential upside of 31.72%. Surgery Partners has a consensus target price of $22.18, suggesting a potential upside of 46.84%. Given Surgery Partners' higher probable upside, analysts clearly believe Surgery Partners is more favorable than Tenet Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenet Healthcare	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.82
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

Tenet Healthcare has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Tenet Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenet Healthcare	$21.31B	0.75	$1.41B	$19.23	9.69
Surgery Partners	$3.31B	0.60	-$77.90M	-$0.60	N/A

Tenet Healthcare has a net margin of 7.94% compared to Surgery Partners' net margin of -2.28%. Tenet Healthcare's return on equity of 25.55% beat Surgery Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenet Healthcare	7.94%	25.55%	5.15%
Surgery Partners	-2.28%	1.04%	0.41%

Tenet Healthcare has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Surgery Partners has a beta of 1.89, meaning that its stock price is 89% more volatile than the broader market.

In the previous week, Surgery Partners had 2 more articles in the media than Tenet Healthcare. MarketBeat recorded 3 mentions for Surgery Partners and 1 mentions for Tenet Healthcare. Surgery Partners' average media sentiment score of 0.93 beat Tenet Healthcare's score of 0.83 indicating that Surgery Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tenet Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Surgery Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Tenet Healthcare beats Surgery Partners on 11 of the 17 factors compared between the two stocks.

How does Surgery Partners compare to Hims & Hers Health?

Surgery Partners (NASDAQ:SGRY) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

Surgery Partners presently has a consensus price target of $22.18, suggesting a potential upside of 46.84%. Hims & Hers Health has a consensus price target of $30.70, suggesting a potential downside of 13.05%. Given Surgery Partners' stronger consensus rating and higher possible upside, analysts plainly believe Surgery Partners is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13

Hims & Hers Health has a net margin of -0.56% compared to Surgery Partners' net margin of -2.28%. Hims & Hers Health's return on equity of 6.10% beat Surgery Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Surgery Partners	-2.28%	1.04%	0.41%
Hims & Hers Health	-0.56%	6.10%	1.52%

63.5% of Hims & Hers Health shares are owned by institutional investors. 2.0% of Surgery Partners shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Hims & Hers Health had 10 more articles in the media than Surgery Partners. MarketBeat recorded 13 mentions for Hims & Hers Health and 3 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.93 beat Hims & Hers Health's score of 0.63 indicating that Surgery Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Surgery Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Surgery Partners has a beta of 1.89, suggesting that its share price is 89% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.35, suggesting that its share price is 135% more volatile than the broader market.

Hims & Hers Health has lower revenue, but higher earnings than Surgery Partners. Hims & Hers Health is trading at a lower price-to-earnings ratio than Surgery Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surgery Partners	$3.31B	0.60	-$77.90M	-$0.60	N/A
Hims & Hers Health	$2.35B	3.48	$128.37M	-$0.09	N/A

Summary

Hims & Hers Health beats Surgery Partners on 10 of the 17 factors compared between the two stocks.

How does Surgery Partners compare to PACS Group?

Surgery Partners (NASDAQ:SGRY) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

In the previous week, PACS Group had 10 more articles in the media than Surgery Partners. MarketBeat recorded 13 mentions for PACS Group and 3 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.93 beat PACS Group's score of 0.07 indicating that Surgery Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Surgery Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	3 Very Positive mention(s)	7 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surgery Partners	$3.31B	0.60	-$77.90M	-$0.60	N/A
PACS Group	$5.29B	1.29	$191.54M	$1.56	27.66

Surgery Partners has a beta of 1.89, meaning that its share price is 89% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, meaning that its share price is 108% less volatile than the broader market.

PACS Group has a net margin of 4.49% compared to Surgery Partners' net margin of -2.28%. PACS Group's return on equity of 26.47% beat Surgery Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Surgery Partners	-2.28%	1.04%	0.41%
PACS Group	4.49%	26.47%	4.36%

Surgery Partners presently has a consensus price target of $22.18, suggesting a potential upside of 46.84%. PACS Group has a consensus price target of $50.60, suggesting a potential upside of 17.29%. Given Surgery Partners' stronger consensus rating and higher probable upside, equities research analysts plainly believe Surgery Partners is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Summary

PACS Group beats Surgery Partners on 9 of the 15 factors compared between the two stocks.

How does Surgery Partners compare to Billiontoone?

Surgery Partners (NASDAQ:SGRY) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk and earnings.

In the previous week, Billiontoone had 11 more articles in the media than Surgery Partners. MarketBeat recorded 14 mentions for Billiontoone and 3 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.93 beat Billiontoone's score of -0.17 indicating that Surgery Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Surgery Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Surgery Partners currently has a consensus price target of $22.18, indicating a potential upside of 46.84%. Billiontoone has a consensus price target of $126.00, indicating a potential upside of 3.18%. Given Surgery Partners' stronger consensus rating and higher possible upside, research analysts plainly believe Surgery Partners is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has lower revenue, but higher earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surgery Partners	$3.31B	0.60	-$77.90M	-$0.60	N/A
Billiontoone	$305.11M	18.41	$7.45M	$0.55	222.04

Billiontoone has a net margin of 0.00% compared to Surgery Partners' net margin of -2.28%. Surgery Partners' return on equity of 1.04% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Surgery Partners	-2.28%	1.04%	0.41%
Billiontoone	N/A	N/A	N/A

Summary

Surgery Partners beats Billiontoone on 8 of the 14 factors compared between the two stocks.

How does Surgery Partners compare to RadNet?

RadNet (NASDAQ:RDNT) and Surgery Partners (NASDAQ:SGRY) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

RadNet has a net margin of -0.66% compared to Surgery Partners' net margin of -2.28%. RadNet's return on equity of 2.77% beat Surgery Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Surgery Partners	-2.28%	1.04%	0.41%

77.9% of RadNet shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Comparatively, 2.0% of Surgery Partners shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

RadNet has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market. Comparatively, Surgery Partners has a beta of 1.89, suggesting that its stock price is 89% more volatile than the broader market.

RadNet currently has a consensus price target of $87.43, suggesting a potential upside of 39.25%. Surgery Partners has a consensus price target of $22.18, suggesting a potential upside of 46.84%. Given Surgery Partners' higher possible upside, analysts plainly believe Surgery Partners is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

RadNet has higher earnings, but lower revenue than Surgery Partners. RadNet is trading at a lower price-to-earnings ratio than Surgery Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.42	-$18.65M	-$0.18	N/A
Surgery Partners	$3.31B	0.60	-$77.90M	-$0.60	N/A

In the previous week, RadNet and RadNet both had 3 articles in the media. RadNet's average media sentiment score of 1.38 beat Surgery Partners' score of 0.93 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Surgery Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

RadNet beats Surgery Partners on 11 of the 16 factors compared between the two stocks.

Get Surgery Partners News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SGRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SGRY vs. The Competition

Export

Metric	Surgery Partners	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.03B	$9.60B	$7.05B	$12.61B
Dividend Yield	N/A	1.62%	2.68%	8.00%
P/E Ratio	-25.85	26.00	27.10	24.26
Price / Sales	0.60	17.40	588.85	117.88
Price / Cash	9.61	14.81	29.22	49.36
Price / Book	0.62	6.05	10.85	6.29
Net Income	-$77.90M	$177.20M	$3.58B	$330.66M
7 Day Performance	-12.02%	-2.07%	-2.12%	-1.35%
1 Month Performance	-1.33%	6.96%	3.27%	-0.64%
1 Year Performance	-32.77%	11.42%	26.33%	19.08%

Surgery Partners Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SGRY Surgery Partners	2.8332 of 5 stars	$15.18 -5.0%	$22.18 +46.1%	-27.5%	$1.97B	$3.31B	N/A	16,000
THC Tenet Healthcare	4.6839 of 5 stars	$206.19 +1.2%	$244.32 +18.5%	+10.9%	$17.55B	$21.31B	10.72	99,000	Positive News Analyst Forecast
HIMS Hims & Hers Health	3.2282 of 5 stars	$38.34 +4.2%	$30.63 -20.1%	-28.2%	$8.52B	$2.35B	N/A	2,442
PACS PACS Group	3.3899 of 5 stars	$44.68 +0.5%	$48.00 +7.4%	+242.5%	$7.04B	$5.29B	28.51	47,455
BLLN Billiontoone	1.8833 of 5 stars	$123.40 +2.5%	$126.00 +2.1%	N/A	$5.54B	$305.11M	N/A	620	News Coverage Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SGRY) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Surgery Partners (SGRY) Competitors

SGRY vs. THC, HIMS, PACS, BLLN, and RDNT

How does Surgery Partners compare to Tenet Healthcare?

Summary

How does Surgery Partners compare to Hims & Hers Health?

Summary

How does Surgery Partners compare to PACS Group?

Summary

How does Surgery Partners compare to Billiontoone?

Summary

How does Surgery Partners compare to RadNet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SGRY vs. The Competition

Surgery Partners Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Surgery Partners (SGRY) Competitors

SGRY vs. THC, HIMS, PACS, BLLN, and RDNT

How does Surgery Partners compare to Tenet Healthcare?

Do institutionals and insiders hold more shares of THC or SGRY?

Do analysts prefer THC or SGRY?

Which has better earnings and valuation, THC or SGRY?

Is THC or SGRY more profitable?

Which has more volatility and risk, THC or SGRY?

Does the media refer more to THC or SGRY?

Summary

How does Surgery Partners compare to Hims & Hers Health?

Do analysts recommend SGRY or HIMS?

Is SGRY or HIMS more profitable?

Do insiders & institutionals have more ownership in SGRY or HIMS?

Does the media prefer SGRY or HIMS?

Which has more volatility & risk, SGRY or HIMS?

Which has better valuation & earnings, SGRY or HIMS?

Summary

How does Surgery Partners compare to PACS Group?

Does the media prefer SGRY or PACS?

Which has preferable valuation and earnings, SGRY or PACS?

Which has more volatility & risk, SGRY or PACS?

Is SGRY or PACS more profitable?

Do analysts prefer SGRY or PACS?

Summary

How does Surgery Partners compare to Billiontoone?

Does the media refer more to SGRY or BLLN?

Do analysts rate SGRY or BLLN?

Which has better earnings and valuation, SGRY or BLLN?

Is SGRY or BLLN more profitable?

Summary

How does Surgery Partners compare to RadNet?

Is RDNT or SGRY more profitable?

Do institutionals and insiders have more ownership in RDNT or SGRY?

Which has more volatility and risk, RDNT or SGRY?

Do analysts recommend RDNT or SGRY?

Which has stronger earnings and valuation, RDNT or SGRY?

Does the media refer more to RDNT or SGRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SGRY vs. The Competition

Surgery Partners Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools